all items  in current results   Refine your search within these categories: 1. Human Genes (group results) 1-acylglycerol-3-phosphate O-acyltransferases [HGNC:AGPAT] (10) 5-HT (serotonin) receptors [HGNC:HTR] (35) A-kinase anchor proteins [HGNC:AKAP] (30) Abhydrolase domain containing [HGNC:ABHD] (9) Acetylcholine receptors, nicotinic [HGNC:CHRN] (31) Acid-sensing (proton-gated) ion channels [HGNC:ASIC] (1) Actin related protein 2/3 complex subunits [HGNC:ARPC] (1) Acyl-CoA synthetase family [HGNC:ACS] (12) Acyl-CoA thioesterases [HGNC:ACOT] (12) ADAM metallopeptidase domain containing [HGNC:ADAM] (12) more... 2. Interaction: Human Genes and Chemicals (group results) Affects (926) Decreases (1203) Increases (1257) 3. Bioactivity 4. Semantic Terms (group results) Entity [STY:T071] (370) Event [STY:T051] (13) A. Anatomy (group results) Body Regions [MESH:D001829] (140) Cardiovascular System [MESH:D002319] (287) Cells [MESH:D002477] (335) Digestive System [MESH:D004064] (87) Embryonic Structures [MESH:D004628] (10) Endocrine System [MESH:D004703] (37) Hemic and Immune Systems [MESH:D006424] (40) Integumentary System [MESH:D034582] (16) Musculoskeletal System [MESH:D009141] (228) Nervous System [MESH:D009420] (68) more... B. Organisms C01. Bacterial Infections and Mycoses (group results) Bacterial Infections [MESH:D001424] (895) Brain Abscess [MESH:D001922] (6) Central Nervous System Infections [MESH:D002494] (3) Infection [MESH:D007239] (1031) Mycoses [MESH:D009181] (87) C02. Virus Diseases (group results) Virus Diseases [MESH:D014777] (1134) C03. Parasitic Diseases (group results) Parasitic Diseases [MESH:D010272] (1007) C04. Neoplasms (group results) Neoplasms [MESH:D009369] (1799) C05. Musculoskeletal Diseases (group results) Musculoskeletal Diseases [MESH:D009140] (1501) C06. Digestive System Diseases (group results) Digestive System Diseases [MESH:D004066] (1702) C07. Stomatognathic Diseases (group results) Stomatognathic Diseases [MESH:D009057] (1206) C08. Respiratory Tract Diseases (group results) Respiratory Tract Diseases [MESH:D012140] (1659) Z. Exceptions (532) C09. Otorhinolaryngologic Diseases (group results) Otorhinolaryngologic Diseases [MESH:D010038] (852) C10. Nervous System Diseases (group results) Nervous System Diseases [MESH:D009422] (1722) Z. Exceptions (1085) C11. Eye Diseases (group results) Eye Diseases [MESH:D005128] (1231) Z. Exceptions (56) C12. Male Urogenital Diseases (group results) Male Urogenital Diseases [MESH:D052801] (1637) C13. Female Urogenital Diseases and Pregnancy Complications (group results) Female Urogenital Diseases [MESH:D052776] (1621) Pregnancy Complications [MESH:D011248] (1079) Z. Exceptions (240) C14. Cardiovascular Diseases (group results) Cardiovascular Diseases [MESH:D002318] (1666) Z. Exceptions (667) C15. Hemic and Lymphatic Diseases: all > Lymphatic Diseases [MESH:D008206] (group results) Histiocytosis [MESH:D015614] (81) Lymphadenitis [MESH:D008199] (7) Lymphangiectasis [MESH:D008200] (5) Lymphatic Abnormalities [MESH:D044148] (70) Lymphedema [MESH:D008209] (34) Lymphoproliferative Disorders [MESH:D008232] (1631) Mucocutaneous Lymph Node Syndrome [MESH:D009080] (41) Pseudolymphoma [MESH:D019310] (4) Splenic Diseases [MESH:D013158] (489) Thymus Hyperplasia [MESH:D013952] (2) more... C16. Congenital, Hereditary, and Neonatal Diseases and Abnormalities (group results) Congenital, Hereditary, and Neonatal Diseases and Abnormalities [MESH:D009358] (1598) C17. Skin and Connective Tissue Diseases (group results) Connective Tissue Diseases [MESH:D003240] (1104) Skin Diseases [MESH:D012871] (1650) Z. Exceptions (1) C18. Nutritional and Metabolic Diseases (group results) Metabolic Diseases [MESH:D008659] (1579) Nutrition Disorders [MESH:D009748] (1127) Z. Exceptions (235) C19. Endocrine System Diseases (group results) Endocrine System Diseases [MESH:D004700] (1594) Z. Exceptions (35) C20. Immune System Diseases (group results) Immune System Diseases [MESH:D007154] (1766) Z. Exceptions (89) C21. Disorders of Environmental Origin C22. Animal Diseases (group results) Animal Diseases [MESH:D000820] (830) C23. Pathological Conditions, Signs and Symptoms (group results) Pathologic Processes [MESH:D010335] (1679) Pathological Conditions, Anatomical [MESH:D020763] (1385) Signs and Symptoms [MESH:D012816] (1581) C24. Occupational Diseases (group results) Occupational Diseases [MESH:D009784] (963) Z. Exceptions (485) C25. Chemically-Induced Disorders (group results) Drug-Related Side Effects and Adverse Reactions [MESH:D064420] (1385) Poisoning [MESH:D011041] (1505) Substance-Related Disorders [MESH:D019966] (1304) C26. Wounds and Injuries (group results) Wounds and Injuries [MESH:D014947] (1133) Z. Exceptions (640) D01. Inorganic Chemicals (group results) Acids [MESH:D000143] (1) Boron Compounds [MESH:D001896] (1) Chlorine Compounds [MESH:D017606] (9) Electrolytes [MESH:D004573] (2) Elements [MESH:D004602] (2) Iron Compounds [MESH:D058085] (2) Metals [MESH:D008670] (2) Nitrogen Compounds [MESH:D017672] (12) Platinum Compounds [MESH:D017671] (9) Selenium Compounds [MESH:D018036] (1) more... D02. Organic Chemicals (group results) Organic Chemicals [MESH:D009930] (580) D03. Heterocyclic Compounds: all > Heterocyclic Compounds [MESH:D006571] (group results) Acids, Heterocyclic [MESH:D000147] (31) Alkaloids [MESH:D000470] (203) Heterocyclic Compounds with 4 or More Rings [MESH:D006576] (64) Heterocyclic Compounds, 1-Ring [MESH:D006573] (887) Heterocyclic Compounds, 2-Ring [MESH:D006574] (936) Heterocyclic Compounds, 3-Ring [MESH:D006575] (130) Heterocyclic Compounds, Bridged-Ring [MESH:D006572] (37) Heterocyclic Oxides [MESH:D006577] (10) Pyrans [MESH:D011714] (278) D04. Polycyclic Compounds Polycyclic Compounds [MESH:D011083] (191) D05. Macromolecular Substances (group results) Macromolecular Substances [MESH:D046911] (7) D06. Hormones, Hormone Substitutes, and Hormone Antagonists (group results) Hormones [MESH:D006728] (1) D08. Enzymes and Coenzymes (group results) Coenzymes [MESH:D003067] (23) Enzymes [MESH:D004798] (9) D09. Carbohydrates (group results) Carbohydrates [MESH:D002241] (96) D10. Lipids (group results) Lipids [MESH:D008055] (24) D12. Amino Acids, Peptides, and Proteins (group results) Amino Acids [MESH:D000596] (18) Peptides [MESH:D010455] (26) Proteins [MESH:D011506] (1) D13. Nucleic Acids, Nucleotides, and Nucleosides (group results) Nucleic Acids [MESH:D009696] (4) Nucleosides [MESH:D009705] (76) Nucleotides [MESH:D009711] (38) D20. Complex Mixtures (group results) Complex Mixtures [MESH:D045424] (1) D23. Biological Factors (group results) Biological Factors [MESH:D001685] (63) D25. Biomedical and Dental Materials (group results) Polymers [MESH:D011108] (1) D26. Pharmaceutical Preparations (group results) Drug Combinations [MESH:D004338] (5) Plant Extracts [MESH:D010936] (1) Street Drugs [MESH:D013287] (1) D27. Chemical Actions and Uses (group results) Pharmacologic Actions [MESH:D020228] (204) Specialty Uses of Chemicals [MESH:D020313] (52) Toxic Actions [MESH:D004786] (21) E. Analytical, Diagnostic and Therapeutic Techniques and Equipment (group results) Diagnosis [MESH:D003933] (314) Therapeutics [MESH:D013812] (91) F. Psychiatry and Psychology (group results) Behavior and Behavior Mechanisms [MESH:D001520] (205) Mental Disorders [MESH:D001523] (338) Psychological Phenomena and Processes [MESH:D011579] (6) G. Phenomena and Processes (group results) Chemical Phenomena [MESH:D055598] (4) Circulatory and Respiratory Physiological Phenomena [MESH:D002943] (142) Genetic Phenomena [MESH:D055614] (330) Musculoskeletal and Neural Physiological Phenomena [MESH:D055687] (14) Physiological Phenomena [MESH:D010829] (118) Reproductive and Urinary Physiological Phenomena [MESH:D012101] (2) I. Anthropology, Education, Sociology and Social Phenomena J. Technology, Industry, Agriculture (group results) Technology, Industry, and Agriculture [MESH:D013676] (1) N. Health Care Recently Viewed Items Go to Item History

These terms define your current search. Click the × to remove a term. C15. Hemic and Lymphatic Diseases: Lymphatic Diseases [MESH:D008206] × D03. Heterocyclic Compounds: Heterocyclic Compounds [MESH:D006571] × 1807 items, grouped by D04. Polycyclic Compounds (view ungrouped items) Polycyclic Compounds [MESH:D011083] (191)    MESH:C004218   tylophorine C004218               MESH:C006794   brevianamide A C006794               MESH:C007020   chlorophyllin C007020               MESH:C007095   cobaltiprotoporphyrin C007095               MESH:C007740   fluorexon C007740               MESH:C011539   protoporphyrinogen C011539               MESH:C014553   MOPP protocol C014553               MESH:C017803   zinc protoporphyrin C017803               MESH:C019215   mitonafide C019215               MESH:C021096   tetra(4-N-methylpyridyl)porphine C021096               MESH:C028025   protoporphyrin IX C028025               MESH:C029569   diacetyldichlorofluorescein C029569               MESH:C032282   COPP protocol C032282               MESH:C032628   tin protoporphyrin IX C032628               MESH:C034078   CVPP protocol C034078               MESH:C034080   CDOP protocol C034080               MESH:C034482   CAV protocol C034482               MESH:C034587   CHOP protocol C034587               MESH:C034588   COP protocol 2 C034588               MESH:C034632   ABVD protocol C034632               MESH:C034856   CHOP-B protocol C034856               MESH:C034857   ACOMLA protocol C034857               MESH:C035000   CAF protocol C035000               MESH:C035353   M-BACOD protocol C035353               MESH:C035405   ChlVPP protocol C035405               MESH:C036337   VAP-cyclo protocol C036337               MESH:C036986   VBA protocol C036986               MESH:C037068   latrunculin B C037068               MESH:C037238   COMP protocol C037238               MESH:C037631   2',7'-dichlorofluorescein C037631               MESH:C039323   ANAVACYM protocol C039323               MESH:C039822   BVCPP protocol C039822               MESH:C040392   OPP protocol C040392               MESH:C042557   B-CAVe protocol C042557               MESH:C042734   rifaximin C042734               MESH:C044361   M-VAC protocol C044361               MESH:C044433   VCP protocol 2 C044433               MESH:C044922   MACOP-B protocol C044922               MESH:C045849   F-MACHOP protocol C045849               MESH:C046414   6-codeinone C046414               MESH:C046983   06-Paris-LA-66 protocol C046983               MESH:C050705   CHIVPP protocol C050705               MESH:C050950   tetrakis(N-methyl-4-pyridiniumyl)porphine manganese(III) complex C050950               MESH:C051019   BAEC protocol C051019               MESH:C051098   OPAL protocol C051098               MESH:C051594   CEOP protocol 1 C051594               MESH:C051595   OEPP protocol C051595               MESH:C052498   FEC protocol C052498               MESH:C052846   PROMACE-CytaBOM protocol C052846               MESH:C053079   tautomycin C053079               MESH:C053429   EBVP protocol C053429               MESH:C053514   CMOPP protocol C053514               MESH:C055421   tin mesoporphyrin C055421               MESH:C056641   MOPP-ABV protocol C056641               MESH:C056642   DHAP protocol C056642               MESH:C056644   ESAP protocol C056644               MESH:C057058   BEAM regimen C057058               MESH:C058069   zinc mesoporphyrin C058069               MESH:C059259   PEEC protocol C059259               MESH:C060154   DAV regimen C060154               MESH:C060229   1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione C060229               MESH:C062889   aspirin, codeine drug combination C062889               MESH:C062938   VEP-THP protocol C062938               MESH:C063463   M-BNCOD protocol C063463               MESH:C063942   UKALL X protocol C063942               MESH:C064396   CVAD protocol C064396               MESH:C066217   rolafagrel C066217               MESH:C066512   CVPP regimen C066512               MESH:C069293   VACOP-B protocol C069293               MESH:C069295   DICE protocol C069295               MESH:C069741   norcantharidin C069741               MESH:C070074   m-ACOD protocol C070074               MESH:C070417   Win 55212-2 C070417               MESH:C070571   ML 7 C070571               MESH:C071945   CHOEP protocol C071945               MESH:C074606   VEEP regimen C074606               MESH:C075765   EVAP protocol C075765               MESH:C076190   BACOD protocol C076190               MESH:C076946   donepezil C076946               MESH:C077194   AIEOP acute lymphoblastic leukemia protocol C077194               MESH:C077579   7-(deoxyguanosin-N(2)-yl)aristolactam I C077579               MESH:C077580   7-(deoxyadenosin-N(6)-yl)aristolactam I C077580               MESH:C078549   xestospongin B C078549               MESH:C079446   EPOCH protocol C079446               MESH:C080222   FPEPIR regimen C080222               MESH:C080815   BEACOPP protocol C080815               MESH:C083136   BFM-ALL 81 protocol C083136               MESH:C083966   NOPE protocol C083966               MESH:C085059   phloxine C085059               MESH:C085925   calcein AM C085925               MESH:C086095   Dexa-BEAM protocol C086095               MESH:C086538   4-amino-1,8-naphthalimide C086538               MESH:C087181   isoniazid, pyrazinamide, rifampin drug combination C087181               MESH:C087651   NOPP protocol C087651               MESH:C087783   EVA regimen C087783               MESH:C092704   MINE protocol C092704               MESH:C093371   Stanford V protocol C093371               MESH:C095104   LG 100268 C095104               MESH:C097003   AL851 protocol C097003               all 191 items...